{"count": 34, "results": [{"_id": "35285549", "pmid": 35285549, "pmcid": "PMC9151484", "title": "Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy", "journal": "J Vet Intern Med", "authors": ["Ward JL", "Guillot E", "Domenig O", "Ware WA", "Yuan L", "Mochel JP"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/jvim.16401", "meta_date_publication": "2022 May", "meta_volume": "36", "meta_issue": "3", "meta_pages": "897-909", "score": 50261.85, "text_hl": "To document RAAS activity in @SPECIES_9685 @@@cats@@@ with @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@SH@@@ or @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@CM@@@ compared to healthy @SPECIES_9685 @@@cats@@@ and determine how RAAS profiles change with @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@ or @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ treatment.", "citations": {"NLM": "Ward JL, Guillot E, Domenig O, Ware WA, Yuan L, Mochel JP. Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy J Vet Intern Med. 2022 May;36(3):897-909. PMID: 35285549", "BibTeX": "@article{35285549, title={Circulating renin-angiotensin-aldosterone system activity in cats with systemic hypertension or cardiomyopathy}, author={Ward JL and Guillot E and Domenig O and Ware WA and Yuan L and Mochel JP}, journal={J Vet Intern Med}, volume={36}, number={3}, pages={897-909}}"}}, {"_id": "33222712", "pmid": 33222712, "title": "The impact of medical interventions on admission characteristics in children with congenital heart disease and cardiomyopathy.", "journal": "Cardiol Young", "authors": ["Loomba RS", "Rausa J", "Dorsey V", "Bronicki RA", "Villarreal EG", "Flores S"], "date": "2021-03-01T00:00:00Z", "doi": "10.1017/S1047951120004175", "meta_date_publication": "2021 Mar", "meta_volume": "31", "meta_issue": "3", "meta_pages": "406-413", "score": 50251.445, "text_hl": "The medical interventions with benefit for all endpoints after multivariate regression analyses in this cohort are @CHEMICAL_Methylprednisolone @CHEMICAL_MESH:D008775 @@@methylprednisolone@@@, @CHEMICAL_Captopril @CHEMICAL_MESH:D002216 @@@captopril@@@, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@, @CHEMICAL_Furosemide @CHEMICAL_MESH:D005665 @@@furosemide@@@, and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. CONCLUSIONS: Diuretics, @CHEMICAL_Steroids @CHEMICAL_MESH:D013256 @@@steroids@@@, angiotensin-converting enzyme inhibitors, calcium channel blockers, and beta blockers all appear to offer beneficial effects in paediatric @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@cardiomyopathy@@@ admission outcomes. ", "citations": {"NLM": "Loomba RS, Rausa J, Dorsey V, Bronicki RA, Villarreal EG, Flores S. The impact of medical interventions on admission characteristics in children with congenital heart disease and cardiomyopathy. Cardiol Young. 2021 Mar;31(3):406-413. PMID: 33222712", "BibTeX": "@article{33222712, title={The impact of medical interventions on admission characteristics in children with congenital heart disease and cardiomyopathy.}, author={Loomba RS and Rausa J and Dorsey V and Bronicki RA and Villarreal EG and Flores S}, journal={Cardiol Young}, volume={31}, number={3}, pages={406-413}}"}}, {"_id": "36565288", "pmid": 36565288, "title": "Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis.", "journal": "Eur J Haematol", "authors": ["Soliman Y", "Abdelaziz A", "Mouffokes A", "Amer BE", "Goudy YM", "Abdelwahab OA", "Badawy MM", "Diab RA", "Elsharkawy A"], "date": "2022-12-24T00:00:00Z", "doi": "10.1111/ejh.13919", "meta_date_publication": "2022 Dec 24", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50247.652, "text_hl": "CONCLUSION: Our meta-analysis found that @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ significantly increases cardiac T2* and decreases MIC, hence decreasing the incidence of @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@cardiomyopathy@@@-related @DISEASE_Iron_Overload @DISEASE_MESH:D019190 @@@iron overload@@@ in @DISEASE_Thalassemia @DISEASE_MESH:D013789 @@@thalassemia@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Soliman Y, Abdelaziz A, Mouffokes A, Amer BE, Goudy YM, Abdelwahab OA, Badawy MM, Diab RA, Elsharkawy A. Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis. Eur J Haematol. 2022 Dec 24;():. PMID: 36565288", "BibTeX": "@article{36565288, title={Efficacy and safety of calcium channel blockers in preventing cardiac siderosis in thalassemia patients: An updated meta-analysis with trial sequential analysis.}, author={Soliman Y and Abdelaziz A and Mouffokes A and Amer BE and Goudy YM and Abdelwahab OA and Badawy MM and Diab RA and Elsharkawy A}, journal={Eur J Haematol}}"}}, {"_id": "1839440", "pmid": 1839440, "title": "A review of amlodipine in myocardial ischaemia.", "journal": "Postgrad Med J", "authors": ["Taylor SH"], "date": "1991-01-01T00:00:00Z", "meta_date_publication": "1991", "meta_volume": "67 Suppl 5", "meta_issue": "", "meta_pages": "S48-51", "score": 50089.53, "text_hl": "A review of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ in @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@myocardial ischaemia@@@.", "citations": {"NLM": "Taylor SH. A review of amlodipine in myocardial ischaemia. Postgrad Med J. 1991;67 Suppl 5():S48-51. PMID: 1839440", "BibTeX": "@article{1839440, title={A review of amlodipine in myocardial ischaemia.}, author={Taylor SH}, journal={Postgrad Med J}, volume={67 Suppl 5}, pages={S48-51}}"}}, {"_id": "1839439", "pmid": 1839439, "title": "Vascular and myocardial effects of amlodipine: an overview.", "journal": "Postgrad Med J", "authors": ["Nayler WG", "Gu XH"], "date": "1991-01-01T00:00:00Z", "meta_date_publication": "1991", "meta_volume": "67 Suppl 5", "meta_issue": "", "meta_pages": "S41-3", "score": 50086.25, "text_hl": "Vascular and @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@myocardial@@@ effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@: an overview.", "citations": {"NLM": "Nayler WG, Gu XH. Vascular and myocardial effects of amlodipine: an overview. Postgrad Med J. 1991;67 Suppl 5():S41-3. PMID: 1839439", "BibTeX": "@article{1839439, title={Vascular and myocardial effects of amlodipine: an overview.}, author={Nayler WG and Gu XH}, journal={Postgrad Med J}, volume={67 Suppl 5}, pages={S41-3}}"}}, {"_id": "31413542", "pmid": 31413542, "pmcid": "PMC6659783", "title": " A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major", "journal": "Drug Des Devel Ther", "authors": ["Khaled A", "Salem HA", "Ezzat DA", "Seif HM", "Rabee H"], "date": "2019-07-22T00:00:00Z", "doi": "10.2147/DDDT.S211630", "meta_date_publication": "2019", "meta_volume": "13", "meta_issue": "", "meta_pages": "2427-2436", "score": 50083.664, "text_hl": " A randomized controlled trial evaluating the effects of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ on @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@myocardial@@@ iron deposition in pediatric @SPECIES_9606 @@@patients@@@ with @DISEASE_beta_Thalassemia @DISEASE_MESH:D017086 @@@thalassemia major@@@", "citations": {"NLM": "Khaled A, Salem HA, Ezzat DA, Seif HM, Rabee H.  A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major Drug Des Devel Ther. 2019;13():2427-2436. PMID: 31413542", "BibTeX": "@article{31413542, title={ A randomized controlled trial evaluating the effects of amlodipine on myocardial iron deposition in pediatric patients with thalassemia major}, author={Khaled A and Salem HA and Ezzat DA and Seif HM and Rabee H}, journal={Drug Des Devel Ther}, volume={13}, pages={2427-2436}}"}}, {"_id": "12891198", "pmid": 12891198, "title": "Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.", "journal": "Am Heart J", "authors": ["Wijeysundera HC", "Hansen MS", "Stanton E", "Cropp AS", "Hall C", "Dhalla NS", "Ghali J", "Rouleau JL", "PRAISE II Investigators"], "date": "2003-08-01T00:00:00Z", "doi": "10.1016/S0002-8703(03)00171-6", "meta_date_publication": "2003 Aug", "meta_volume": "146", "meta_issue": "2", "meta_pages": "291-7", "score": 50072.7, "text_hl": "Neurohormones and oxidative stress in nonischemic @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@cardiomyopathy@@@: relationship to survival and the effect of treatment with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@.", "citations": {"NLM": "Wijeysundera HC, Hansen MS, Stanton E, Cropp AS, Hall C, Dhalla NS, Ghali J, Rouleau JL, PRAISE II Investigators. Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine. Am Heart J. 2003 Aug;146(2):291-7. PMID: 12891198", "BibTeX": "@article{12891198, title={Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine.}, author={Wijeysundera HC and Hansen MS and Stanton E and Cropp AS and Hall C and Dhalla NS and Ghali J and Rouleau JL and PRAISE II Investigators}, journal={Am Heart J}, volume={146}, number={2}, pages={291-7}}"}}, {"_id": "27062235", "pmid": 27062235, "title": "Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research.", "journal": "Can J Cardiol", "authors": ["Oudit GY", "Backx PH"], "date": "2016-08-01T00:00:00Z", "doi": "10.1016/j.cjca.2015.11.017", "meta_date_publication": "2016 Aug", "meta_volume": "32", "meta_issue": "8", "meta_pages": "938-40", "score": 50070.75, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ Therapy for @CHEMICAL_Iron @CHEMICAL_MESH:D007501 @@@Iron@@@-Overload @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@Cardiomyopathy@@@: The Enduring Value of Translational Research.", "citations": {"NLM": "Oudit GY, Backx PH. Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research. Can J Cardiol. 2016 Aug;32(8):938-40. PMID: 27062235", "BibTeX": "@article{27062235, title={Amlodipine Therapy for Iron-Overload Cardiomyopathy: The Enduring Value of Translational Research.}, author={Oudit GY and Backx PH}, journal={Can J Cardiol}, volume={32}, number={8}, pages={938-40}}"}}, {"_id": "8448585", "pmid": 8448585, "title": "Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs.", "journal": "Br J Pharmacol", "authors": ["Sobey CG", "Dalipram RA", "Woodman OL"], "date": "1993-02-01T00:00:00Z", "doi": "10.1111/j.1476-5381.1993.tb12807.x", "meta_date_publication": "1993 Feb", "meta_volume": "108", "meta_issue": "2", "meta_pages": "342-7", "score": 50067.496, "text_hl": "@CHEMICAL_Allopurinol @CHEMICAL_MESH:D000493 @@@Allopurinol@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ improve coronary vasodilatation after @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@myocardial ischaemia@@@ and reperfusion in anaesthetized @SPECIES_9615 @@@dogs@@@.", "citations": {"NLM": "Sobey CG, Dalipram RA, Woodman OL. Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs. Br J Pharmacol. 1993 Feb;108(2):342-7. PMID: 8448585", "BibTeX": "@article{8448585, title={Allopurinol and amlodipine improve coronary vasodilatation after myocardial ischaemia and reperfusion in anaesthetized dogs.}, author={Sobey CG and Dalipram RA and Woodman OL}, journal={Br J Pharmacol}, volume={108}, number={2}, pages={342-7}}"}}, {"_id": "10463522", "pmid": 10463522, "title": "Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.", "journal": "Clin Ther", "authors": ["O'Connor CM", "Radensky PW", "Unger AN", "Martin BC"], "date": "1999-07-01T00:00:00Z", "doi": "10.1016/S0149-2918(00)80027-2", "meta_date_publication": "1999 Jul", "meta_volume": "21", "meta_issue": "7", "meta_pages": "1254-65", "score": 50065.89, "text_hl": "Hospital use and costs among @SPECIES_9606 @@@patients@@@ with nonischemic @<m>DISEASE_Cardiomyopathies</m> @DISEASE_MESH:D009202 @@@cardiomyopathy@@@ in the first prospective randomized @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ survival evaluation study.", "citations": {"NLM": "O'Connor CM, Radensky PW, Unger AN, Martin BC. Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study. Clin Ther. 1999 Jul;21(7):1254-65. PMID: 10463522", "BibTeX": "@article{10463522, title={Hospital use and costs among patients with nonischemic cardiomyopathy in the first prospective randomized amlodipine survival evaluation study.}, author={O'Connor CM and Radensky PW and Unger AN and Martin BC}, journal={Clin Ther}, volume={21}, number={7}, pages={1254-65}}"}}]}